000	00000nam 2200000zi 4500
001	9.948712
003	CaOODSP
005	20250530083521
006	m     o  d f
007	cr cn|||||||||
008	250304e202502  onca    o    f000 0 eng d
020	|a9780660761541
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aH14-651/2025E-PDF
245	00|a2025 Pharmacare : |bfocus testing of creatives : research report / |cprepared for Health Canada.
264	1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |cFebruary 2025.
264	1|c©2025
300	|a1 online resource (55 pages) : |bcolour illustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aIssued also in French under title: Régime d'assurance médicaments 2025 : groupes de discussion pour tester des créatifs publicitaires : rapport de recherche.
500	|a"Supplier name: Earnscliffe Strategy Group."
500	|a"Contract number: CW2381156."
500	|a"Registration number: POR # 072-24."
520	|a"Health Canada is planning an advertising campaign to increase awareness of Pharmacare among those impacted: 1) people living with diabetes, and; 2) women and gender diverse people of reproductive age. Focus testing is an important element to provide insights and refine the campaign's creative approach moving forward. As this is an entirely new initiative for Canadians, Health Canada was looking to learn what types of creatives best resonate with these target audiences"--Page 1.
650	0|aPharmaceutical services insurance|zCanada|xPublic opinion.
650	0|aGovernment advertising|zCanada|xPublic opinion.
650	0|aPublic opinion|zCanada.
710	1 |aCanada. |bHealth Canada, |eissuing body.
710	2 |aEarnscliffe Strategy Group, |econsultant.
775	08|tRégime d'assurance médicaments 2025 : |w(CaOODSP)9.948713
856	40|qPDF|s2.76 MB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H14-651-2025-eng.pdf
856	4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2025/072-24-e/index.html